MustGrow Biologics Corp. (TSXV: MGRO)
Canada
· Delayed Price · Currency is CAD 1.810
-0.030 (-1.63%)
Nov 22, 2024, 3:59 PM EST
MustGrow Biologics Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | 4.71 | 4.71 | 0.01 | 0.01 | - | - | Upgrade
|
| Revenue Growth (YoY) | 360159.94% | 72630.36% | -49.65% | - | - | - | Upgrade
|
| Cost of Revenue | 0.24 | 0.38 | 0.3 | 0.2 | 0.19 | 0.07 | Upgrade
|
| Gross Profit | 4.47 | 4.33 | -0.29 | -0.19 | -0.19 | -0.07 | Upgrade
|
| Selling, General & Admin | 2.33 | 2.31 | 2.79 | 1.81 | 2.09 | 1.07 | Upgrade
|
| Research & Development | 0.71 | 0.86 | 0.48 | 0.46 | 0.15 | 0.08 | Upgrade
|
| Operating Expenses | 4.37 | 4.54 | 4.96 | 2.54 | 3.01 | 1.28 | Upgrade
|
| Operating Income | 0.1 | -0.21 | -5.25 | -2.73 | -3.2 | -1.35 | Upgrade
|
| Interest Expense | - | - | -0.01 | -0.05 | -0.05 | -0.05 | Upgrade
|
| Interest & Investment Income | 0.22 | 0.21 | 0.1 | 0 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.06 | -0.08 | 0.03 | -0 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.69 | -0.59 | -0.43 | -0.28 | -0.17 | -0.12 | Upgrade
|
| EBT Excluding Unusual Items | -0.42 | -0.68 | -5.57 | -3.06 | -3.42 | -1.52 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.11 | - | Upgrade
|
| Pretax Income | -0.42 | -0.68 | -5.57 | -3.06 | -3.31 | -1.52 | Upgrade
|
| Net Income | -0.42 | -0.68 | -5.57 | -3.06 | -3.31 | -1.52 | Upgrade
|
| Net Income to Common | -0.42 | -0.68 | -5.57 | -3.06 | -3.31 | -1.52 | Upgrade
|
| Shares Outstanding (Basic) | 51 | 50 | 49 | 44 | 37 | 25 | Upgrade
|
| Shares Outstanding (Diluted) | 51 | 50 | 49 | 44 | 37 | 25 | Upgrade
|
| Shares Change (YoY) | 2.49% | 1.80% | 12.06% | 17.22% | 47.52% | 22.69% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.11 | -0.07 | -0.09 | -0.06 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.11 | -0.07 | -0.09 | -0.06 | Upgrade
|
| Free Cash Flow | -0.19 | -0.29 | -3.26 | -2.41 | -2.58 | -1.35 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.07 | -0.06 | -0.07 | -0.05 | Upgrade
|
| Gross Margin | 94.88% | 91.84% | - | - | - | - | Upgrade
|
| Operating Margin | 2.05% | -4.48% | -81067.00% | -21207.43% | - | - | Upgrade
|
| Profit Margin | -9.00% | -14.37% | -85905.87% | -23808.18% | - | - | Upgrade
|
| Free Cash Flow Margin | -3.97% | -6.26% | -50278.41% | -18741.00% | - | - | Upgrade
|
| EBIT | 0.1 | -0.21 | -5.25 | -2.73 | -3.2 | -1.35 | Upgrade
|
| EBIT Margin | 2.05% | -4.48% | - | - | - | - | Upgrade
|
| Revenue as Reported | 4.71 | 4.71 | 0.01 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.